View Older Stories View More Recent Stories

Feb 19, 2021 01:26PM Abbott Declares 389th Consecutive Quarterly Dividend
Jan 27, 2021 07:30AM Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021
Jan 26, 2021 07:45AM Abbott's (ABT) Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
Jan 26, 2021 07:45AM Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab
Jan 20, 2021 07:47AM Abbott (ABT) Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip Device
Jan 20, 2021 07:45AM Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip™ Device
Jan 14, 2021 09:00AM Abbott to Launch the NeuroSphere™ myPath™ Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
Jan 12, 2021 09:00AM Abbott Announces Fulfillment of Federal Government Purchase of 150 Million BinaxNOW™ COVID-19 Rapid Tests and Is Now Ready to Support Commercial Distribution
Jan 11, 2021 09:09AM Abbott (ABT) Receives FDA 510(k) Clearance for the First Rapid Handheld Blood Test for Concussions
Jan 11, 2021 09:00AM Abbott Receives FDA 510(k) Clearance for the First Rapid Handheld Blood Test for Concussions
Jan 6, 2021 09:00AM Abbott Hosts Conference Call for Fourth-Quarter Earnings
Dec 22, 2020 09:00AM As Vaccines Roll Out, Americans See COVID-19 Testing as Important Partner
Dec 18, 2020 09:00AM Abbott to Present at J.P. Morgan Healthcare Conference
Dec 17, 2020 04:53PM Abbott (ABT) Announces FDA Approves Labeling Update for its HeartMate 3 Heart Pump for use in Pediatric Patients
Dec 17, 2020 04:52PM FDA Approves Labeling Update for Abbott's HeartMate 3 Heart Pump for use in Pediatric Patients
Dec 16, 2020 01:02PM Abbott (ABT) BinaxNOW COVID-19 At-Home Rapid Test Receives FDA EUA
Dec 16, 2020 12:55PM Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform
Dec 15, 2020 09:04AM Abbott (ABT) Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test
Dec 15, 2020 09:00AM Abbott Receives CE Mark for its COVID-19 IgG Quantitative Antibody Blood Test
Dec 14, 2020 09:00AM Abbott Develops New Pedialyte® Hydration Solution to Help Support Immune Health
Dec 11, 2020 11:00AM Abbott Increases Quarterly Dividend by 25%
Dec 2, 2020 08:06AM Abbott's (ABT) FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Dec 2, 2020 08:00AM Abbott's FreeStyle Libre 2 Now Approved for Adults and Children with Diabetes in Canada, Featuring Unsurpassed 14-Day Accuracy and Optional Alarms
Nov 18, 2020 09:00AM Abbott Becomes First Anchor Sponsor of American Diabetes Association's Health Equity Now Initiative to Advance Access to Care and Technology for People with Diabetes
Nov 16, 2020 10:20AM Abbott Named Industry Sustainability Leader for the Eighth Year in a Row on the Dow Jones Sustainability Index (DJSI)
Nov 10, 2020 09:05AM Abbott (ABT) Announces the U.S. Launch of the IonicRF Generator for Use in Patients Living With Chronic Pain
Nov 10, 2020 09:00AM Abbott Announces the U.S. Launch of the IonicRF™ Generator for Use in Patients Living With Chronic Pain
Oct 30, 2020 09:00AM Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip™ Device
Oct 21, 2020 07:30AM Abbott Reports Third-Quarter 2020 Results; Achieves Strong Double-Digit Earnings Growth and Raises Guidance
Oct 20, 2020 08:00AM Absolute Appoints Steven Gatoff as Chief Financial Officer
Oct 19, 2020 02:56PM Absolute Declares Quarterly Dividend
Oct 19, 2020 07:15AM Improved Mental and Physical Condition is Directly Linked to Nutrition, Study Shows
Oct 15, 2020 08:00AM Absolute Unveils Enhanced Global Partner Program
Oct 14, 2020 08:00AM Absolute Launches New Mobile App to Enable Customers to Secure At-Risk Endpoints Anytime, Anywhere
Oct 12, 2020 09:01AM Abbott (ABT) Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test
Oct 12, 2020 09:00AM Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test
Oct 7, 2020 08:09AM Abbott (ABT) Releases ID NOW COVID-19 Interim Clinical Study Results from 1,003 People
Oct 7, 2020 08:00AM Abbott Releases ID NOW™ COVID-19 Interim Clinical Study Results from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health
Sep 28, 2020 09:05AM Abbott (ABT) FreeStyle Libre 3 System Receives CE Mark
Sep 28, 2020 09:00AM Abbott's FreeStyle® Libre 3 System Receives CE Mark - Features World's Smallest, Thinnest Sensor with Best-in-Class Performance at the Same Low Cost for People with Diabetes
Sep 21, 2020 09:07AM Abbott (ABT) Receives CE Mark for Next-Generation MitraClip Heart Valve Repair Device to Treat Mitral Regurgitation
Sep 21, 2020 09:02AM Abbott Receives CE Mark for Next-Generation MitraClip™ Heart Valve Repair Device to Treat Mitral Regurgitation
Sep 21, 2020 09:00AM Abbott Hosts Conference Call for Third-Quarter Earnings
Sep 17, 2020 11:39AM Abbott Declares 387th Consecutive Quarterly Dividend
Sep 17, 2020 09:02AM Abbott (ABT) Introduces Libre Sense Glucose Sport Biosensor in Europe
Sep 17, 2020 09:00AM Abbott Introduces Libre Sense Glucose Sport Biosensor in Europe, World's First Glucose Biosensor Designed for Athletes
Sep 16, 2020 08:00AM New Research from Absolute Underscores Complexities, Gaps in K-12 Device and Data Security Driven by Accelerated Shift to Distance Learning
Sep 9, 2020 08:00AM Absolute Accelerates Endpoint Resilience and Operational Agility for Customers in Era of Remote Work and Distance Learning
Sep 7, 2020 11:42AM From Target to Twitter, U.S. companies urge workers to vote
Sep 3, 2020 09:00AM Abbott Announces Start of Trial to Evaluate the New Esprit™ BTK Drug-Eluting Resorbable Scaffold
View More Recent Stories View Older Stories